PRECISION BIOSCIENCES INC (DTIL) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US74019P2074
PRECISION BIOSCIENCES INC financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 34.26 m USD |
| Operating income | -52.15 m USD |
| EBIT | -44.30 m USD |
| Net income | -45.72 m USD |
| Diluted EPS – continuing operations | -3.56 USD |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About PRECISION BIOSCIENCES INC
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-DMD (Excision) for the treatment of Duchenne muscular dystrophy. In addition, the company develops PBGENE-3243 for the treatment of m.3243 associated mitochondrial diseases; and iECURE-OTC (Insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with TG Cell Therapy, Inc. to develop, manufacture, and commercialize azercabtagene zapreleucel for autoimmune diseases and other indications; and iECURE, Inc., an ARCUS-mediated targeted gene insertion. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
More stocks
- MC Group Public Company Limited (MC.BK)
- Addcn Technology Co Ltd (5287.TWO)
- Holidaycheck Group (HOC.HM)
- Chongqing Wanli New Energy Co Ltd (600847.SS)
- Cruzeiro do Sul Educacional S.A (CSED3.SA)
- BICYCLE THERAPEUTICS PLC (BCYC)
- Hongda High-Tech Holding Co Ltd (002144.SZ)
- Global IBO Group Ltd (GIBO)
- Springsnow Food Group Co Ltd (605567.SS)
- Shanghai Xintonglian Packaging Co Ltd (603022.SS)
- Hangzhou Chuhuan Science & Technology Co. Ltd. A (001336.SZ)
- KINGSWAY Corp (KWY)
Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.